Healthdirect Free Australian health advice you can count on.

Medical problem? Call 1800 022 222. If you need urgent medical help, call triple zero immediately

healthdirect Australia is a free service where you can talk to a nurse or doctor who can help you know what to do.

beginning of content

Brand name: BCG Vaccine (Sanofi Pasteur)

BCG Vaccine (Sanofi Pasteur) is a medicine containing the active ingredient(s) bcg vaccine. On this page you will find out more about BCG Vaccine (Sanofi Pasteur), including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.

Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.

Active ingredient in this medicine: bcg vaccine

Information for medicine and pack size:
BCG Vaccine (Sanofi Pasteur) (1 x 1.5 mg vaccine vial, 1 x 1.5 mL inert diluent vial), 1 pack

Consumer Medicine Information leaflet:

This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.

Read leaflet

What this medicine is for

BCG Vaccine is recommended for active immunisation in high risk groups. The NHMRC recommendation for BCG vaccination are: BCG is recommended for use in 3 groups of infants: . Aboriginal and Torres Strait Islander neonates in regions of high incidence; . Neonates born to patients with leprosy; . Children under the age of 5 years who will be travelling to live in countries of high tuberculosis prevalence for long periods. BCG vaccination should be considered for the following children and adolescents: .Neonates who will be living in a household which includes immigrants or visitors recently arrived from countries of high prevalence (this also applies to neonates in families who have returned to visit the homes of relatives in countries of high prevalence); . Children and adolescents aged less than 16 years who continue to be exposed to a patient with active tuberculosis, and where the child or adolescent cannot be placed on isoniazid therapy or the active case has organisms resistant to both isoniazid and rifampicin. In addition to the above categories, there are other groups of individuals who are at increased risk of tuberculosis, but for whom the value of BCG vaccine is less certain. These groups are: . Health care workers with a high risk of exposure to tuberculosis, such as staff of chest clinics and tuberculosis wards, physiotherapists, diagnostic laboratory staff, autopsy room staff, and most medical and nursing staff of public hospitals; . Travellers over the age of 5 years who will spend prolonged periods in countries of high tuberculosis prevalence. . A tuberculin test should be performed prior to BCG vaccination in all individuals, except in infants under 6 months of age. Only subjects in whom a test dose of 10 units produces less than 5mm of induration should receive BCG. BCG vaccination has no value in the treatment of tuberculosis disease.

Table of characteristics
Table of characteristics
Active ingredient
Medicine schedule
1 vial vaccine with diluent: Prescription Only Medicine, or Prescription Animal Remedy
Part 1
Part 1
Visual appearance A white powdery freeze-dried plug.
Dosage Form Injection, powder for
Route of administration Intradermal
Part 2
Part 2
Visual appearance A clear colourless solution.
Dosage Form Diluent, not applicable
Route of administration Intradermal

There is one type of pack available.

Pack type 1
Pack type 1
Type Vial
Storage temperature Store at 2 to 8 degrees Celsius
Storage conditions Protect from Light,Do not Freeze
Life time 32 Months
We were unable to verify that this medicine is available on the PBS (Pharmaceutical Benefits Scheme). Please consult your pharmacist if you need further information

The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.

Go to PBS site

Is this medication banned in sport?

Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.

Go to ASADA site

The information displayed on this page is authored by Healthdirect Australia, or obtained from trusted sources.

Healthdirect 24hr 7 days a week hotline

24 hour health advice and information you can count on

1800 022 222

Government Accredited with over 140 information partners

We are a government-funded service, providing quality, approved health information

Australian Government, health department logo ACT Government logo New South Wales government, health department logo Northen Territory Government logo Government of South Australia, health department logo Tasmanian government logo Government of Western Australia, health department logo